Paul Lammers's Net Worth

$2.68 Thousand

Estimate Recalculated Nov 1, 2024 06:30AM EST

Who is Paul Lammers?

Paul Lammers does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Salarius Pharmaceuticals, Inc., Mirna Therapeutics, Inc., and REPROS THERAPEUTICS INC..

SEC CIK

Paul Lammers's CIK is 0001457289

Past Insider Trading and Trends

2020 was Paul Lammers's most active year for acquiring shares with 2 total transactions. Paul Lammers's most active month to acquire stocks was the month of December. 2009 saw Paul Lammers paying a total of $0.00 for 300,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Salarius Pharmaceuticals, Inc. (SLRX) Snapshot price: $1.56

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 20
Form 4
+517.99%
1.44K
—
—
1.72K
Jan 3
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Dec 2
Form 4
—
0
—
—
0
Mar 23
Form 4
—
0
—
—
0
Sep 10
Form 3
—
0
—
—
0
No matching records found

Mirna Therapeutics, Inc. (SYBX) Snapshot price: $1.58

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
Sep 30
Form 3
—
0
—
—
0
No matching records found

REPROS THERAPEUTICS INC. No price found

President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 18
Form 3
—
0
—
—
0
No matching records found